These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 12713734)

  • 1. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
    Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
    DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
    Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
    Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.
    Chang CH; Scott GK; Kuo WL; Xiong X; Suzdaltseva Y; Park JW; Sayre P; Erny K; Collins C; Gray JW; Benz CC
    Oncogene; 1997 Apr; 14(13):1617-22. PubMed ID: 9129154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism.
    Prescott JD; Koto KS; Singh M; Gutierrez-Hartmann A
    Mol Cell Biol; 2004 Jun; 24(12):5548-64. PubMed ID: 15169914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
    Chang CH; Scott GK; Baldwin MA; Benz CC
    Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M; Darley M; Primrose JN; Blaydes JP
    Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ErbB2 activation of ESX gene expression.
    Neve RM; Ylstra B; Chang CH; Albertson DG; Benz CC
    Oncogene; 2002 May; 21(24):3934-8. PubMed ID: 12032832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor.
    Watabe T; Yoshida K; Shindoh M; Kaya M; Fujikawa K; Sato H; Seiki M; Ishii S; Fujinaga K
    Int J Cancer; 1998 Jul; 77(1):128-37. PubMed ID: 9639404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic conversion alters the transcriptional properties of ets.
    Wasylyk C; Wasylyk B
    Cell Growth Differ; 1992 Sep; 3(9):617-25. PubMed ID: 1329927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
    Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS
    Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism.
    Lindemann RK; Ballschmieter P; Nordheim A; Dittmer J
    J Biol Chem; 2001 Dec; 276(49):46661-70. PubMed ID: 11590145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.
    O'Hagan RC; Hassell JA
    Oncogene; 1998 Jan; 16(3):301-10. PubMed ID: 9467955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells.
    Scott GK; Daniel JC; Xiong X; Maki RA; Kabat D; Benz CC
    J Biol Chem; 1994 Aug; 269(31):19848-58. PubMed ID: 7914192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.
    Galang CK; García-Ramírez J; Solski PA; Westwick JK; Der CJ; Neznanov NN; Oshima RG; Hauser CA
    J Biol Chem; 1996 Apr; 271(14):7992-8. PubMed ID: 8626480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
    Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
    Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products.
    Chen L; Zhang W; Fregien N; Pierce M
    Oncogene; 1998 Oct; 17(16):2087-93. PubMed ID: 9798679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ets-1 activates parathyroid hormone-related protein gene expression in tumorigenic breast epithelial cells.
    Cataisson C; Gordon J; Roussière M; Abdalkhani A; Lindemann R; Dittmer J; Foley J; Bouizar Z
    Mol Cell Endocrinol; 2003 Jun; 204(1-2):155-68. PubMed ID: 12850290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.
    Goueli BS; Janknecht R
    Mol Cell Biol; 2004 Jan; 24(1):25-35. PubMed ID: 14673140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.